US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 28.810
  • +0.110+0.38%
Close Dec 24 13:00 ET
  • 28.810
  • 0.0000.00%
Post 17:01 ET
2.39BMarket Cap-18.23P/E (TTM)

About Beam Therapeutics Company

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Company Profile

SymbolBEAM
Company NameBeam Therapeutics
Listing DateFeb 6, 2020
Issue Price17.00
Founded2017
CEOMr. John Evans
MarketNASDAQ
Employees436
Fiscal Year Ends12-31
Address238 Main Street,9th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142-1016
Phone1-857-327-8775

Company Executives

  • Name
  • Position
  • Salary
  • John Evans
  • Chief Executive Officer, Principal Accounting Officer and Director
  • 6.28M
  • Sravan K. Emany
  • Chief Financial Officer
  • --
  • Dr. Christine Bellon, PhD
  • Chief Legal Officer and Secretary
  • 2.28M
  • Dr. Amy Simon, M.D.
  • Chief Medical Officer
  • 2.55M
  • Dr. Giuseppe Ciaramella, PhD
  • President
  • 2.79M
  • Chirfi Guindo
  • Director
  • --
  • Kathleen E. Walsh
  • Independent Director
  • 447.72K
  • Christi Shaw
  • Independent Director
  • 772.68K
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 435.22K
  • Dr. Carole Ho, M.D.
  • Independent Director
  • 442.72K
  • Dr. Mark C. Fishman, M.D.
  • Lead Independent Director
  • 465.22K
  • Graham K. Cooper
  • Independent Director
  • 450.22K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.